Supurva Healthcare Group, Inc.
SPRV · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 0.00% | -0.62% | -1.46% |
| EV / EBITDA | 0.00 | 0.00 | 0.00 | 1.66 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | -44.06% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.02 | 0.03 | 0.04 | 0.06 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 51.15% | 21.49% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 1.20 |
| Interest Coverage | -1.47 | -2.49 | -2.75 | 19.26 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |